Works matching IS 13866346 AND DT 2022 AND VI 52 AND IP 3

Results: 10
    1
    2
    3

    Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.

    Published in:
    Hepatology Research, 2022, v. 52, n. 3, p. 235, doi. 10.1111/hepr.13739
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Toyoda, Hidenori;
    • Nakamuta, Makoto;
    • Takaguchi, Koichi;
    • Watanabe, Tsunamasa;
    • Hiraoka, Atsushi;
    • Uojima, Haruki;
    • Ishikawa, Toru;
    • Iwasa, Motoh;
    • Tada, Toshifumi;
    • Nozaki, Akito;
    • Chuma, Makoto;
    • Fukunishi, Shinya;
    • Asano, Toru;
    • Ogawa, Chikara;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Hotta, Naoki
    Publication type:
    Article
    4
    5
    6

    Predictors associated with a better response to the Japanese aluminum‐free hepatitis A vaccine, Aimmugen<sup>®</sup>, for people living with HIV.

    Published in:
    Hepatology Research, 2022, v. 52, n. 3, p. 227, doi. 10.1111/hepr.13736
    By:
    • Koga, Michiko;
    • Senkoji, Tomoe;
    • Kubota, Megumi;
    • Ishizaka, Aya;
    • Mizutani, Taketoshi;
    • Sedohara, Ayako;
    • Ikeuchi, Kazuhiko;
    • Kikuchi, Tadashi;
    • Adachi, Eisuke;
    • Saito, Makoto;
    • Koibuchi, Tomohiko;
    • Hosomichi, Kazuyoshi;
    • Ohashi, Jun;
    • Kawana‐Tachikawa, Ai;
    • Matano, Tetsuro;
    • Tsutsumi, Takeya;
    • Yotsuyanagi, Hiroshi
    Publication type:
    Article
    7
    8

    Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.

    Published in:
    Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    9

    Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis.

    Published in:
    Hepatology Research, 2022, v. 52, n. 3, p. 269, doi. 10.1111/hepr.13732
    By:
    • Chuma, Makoto;
    • Uojima, Haruki;
    • Hattori, Nobuhiro;
    • Arase, Yoshitaka;
    • Fukushima, Taito;
    • Hirose, Shunji;
    • Kobayashi, Satoshi;
    • Ueno, Makoto;
    • Tezuka, Shun;
    • Iwasaki, Shuichiro;
    • Wada, Naohisa;
    • Kubota, Kousuke;
    • Tsuruya, Kota;
    • Shimma, Yoshimasa;
    • Hiroki, Ikeda;
    • Takuya, Ehira;
    • Tokoro, Chikako;
    • Iwase, Shigeru;
    • Miura, Yuki;
    • Moriya, Satoshi
    Publication type:
    Article
    10

    Issue Information.

    Published in:
    Hepatology Research, 2022, v. 52, n. 3, p. 225, doi. 10.1111/hepr.13654
    Publication type:
    Article